According to Straits Research, the global paraneoplastic syndrome market size was valued at USD 455 Million in 2022. It is projected to reach from USD XX Million in 2023 to USD 768 Million by 2031, growing at a CAGR of 6% during the forecast period (2023–2031).
Comments
0 comment